A detailed history of Alliancebernstein L.P. transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 56,870 shares of SRRK stock, worth $1.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
56,870
Previous 56,870 -0.0%
Holding current value
$1.51 Million
Previous $473,000 3.81%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$13.2 - $17.76 $421,476 - $567,076
31,930 Added 128.03%
56,870 $1.01 Million
Q4 2023

Feb 14, 2024

BUY
$6.52 - $20.32 $81,826 - $255,016
12,550 Added 101.29%
24,940 $468,000
Q3 2023

Nov 14, 2023

BUY
$6.02 - $7.76 $74,587 - $96,146
12,390 New
12,390 $87,000
Q2 2022

Aug 15, 2022

SELL
$4.66 - $13.96 $133,742 - $400,652
-28,700 Closed
0 $0
Q2 2021

Jul 30, 2021

BUY
$26.34 - $46.62 $5,268 - $9,324
200 Added 0.7%
28,700 $829,000
Q1 2021

May 06, 2021

BUY
$45.96 - $68.02 $36,768 - $54,416
800 Added 2.89%
28,500 $1.44 Million
Q4 2020

Feb 08, 2021

BUY
$13.72 - $51.57 $63,112 - $237,222
4,600 Added 19.91%
27,700 $1.34 Million
Q2 2020

Aug 13, 2020

BUY
$10.37 - $20.64 $26,961 - $53,664
2,600 Added 12.68%
23,100 $421,000
Q1 2020

May 14, 2020

BUY
$9.63 - $17.14 $10,593 - $18,854
1,100 Added 5.67%
20,500 $248,000
Q3 2019

Nov 14, 2019

BUY
$8.95 - $15.72 $38,485 - $67,596
4,300 Added 28.48%
19,400 $174,000
Q2 2019

Aug 14, 2019

BUY
$14.61 - $22.45 $220,611 - $338,995
15,100 New
15,100 $239,000

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $1.37B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.